GSK Stockmann advised the LHI Group, based in Pullach, on extending the regulatory AIFM authorisation of LHI Kapitalverwaltungsgesellschaft mbH.
LHI Kapitalverwaltungsgesellschaft mbH has been granted an extension to its financial portfolio management authorisation by the German Federal Financial Supervisory Authority (BaFin), and has increased its capital by two million euros to six million euros. This was accompanied by the merger of LHI Capital Management GmbH into LHI Kapitalverwaltungsgesellschaft mbH. This move enables the LHI Group, one of the most successful providers of investment and asset management services in Germany, to consolidate its investment business into a standalone entity, thereby strengthening its market position among institutional and professional investors.
A GSK Stockmann team led by Munich partners Oliver Glück and Andreas Dimmling provided the LHI Group with comprehensive advice on regulatory, corporate and employment law issues in connection with the extension of the authorisation and the strategic realignment of the LHI Group.
Advisers of the LHI Group at GSK Stockmann:
Dr Oliver Glück (lead, Financial Services), Dr Dominik Stolz (Financial Services), Andreas Dimmling, Christina Lorf (both Corporate), Dr Philipp Kuhn, Raphaela Guderian (both Employment Law)
